150 related articles for article (PubMed ID: 15936212)
1. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor.
Kim WY; Fayazi Z; Bao X; Higgins D; Kazemi-Esfarjani P
Mol Cell Neurosci; 2005 Aug; 29(4):536-44. PubMed ID: 15936212
[TBL] [Abstract][Full Text] [Related]
2. The myeloid leukemia factor interacts with COP9 signalosome subunit 3 in Drosophila melanogaster.
Sugano W; Ohno K; Yoneda-Kato N; Kato JY; Yamaguchi M
FEBS J; 2008 Feb; 275(3):588-600. PubMed ID: 18199288
[TBL] [Abstract][Full Text] [Related]
3. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
[TBL] [Abstract][Full Text] [Related]
4. Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration.
Nelson B; Nishimura S; Kanuka H; Kuranaga E; Inoue M; Hori G; Nakahara H; Miura M
Cell Death Differ; 2005 Aug; 12(8):1115-23. PubMed ID: 15861189
[TBL] [Abstract][Full Text] [Related]
5. Neuronal toxicity of expanded polyglutamine depends on intracellular distribution in addition to the expression level.
Satoh M; Shimada A; Kawamura N; Chiba Y; Yoshikawa K; Ishii S; Furukawa A; Kumagai N; Hosokawa M
Neuropathology; 2008 Oct; 28(5):485-96. PubMed ID: 18384512
[TBL] [Abstract][Full Text] [Related]
6. Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice.
Li ZF; Wu X; Jiang Y; Liu J; Wu C; Inagaki M; Izawa I; Mizisin AP; Engvall E; Shelton GD
J Neurol Sci; 2008 Jan; 264(1-2):77-86. PubMed ID: 17854834
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of molecular chaperone gene expression in polyglutamine disease.
Huen NY; Chan HY
Biochem Biophys Res Commun; 2005 Sep; 334(4):1074-84. PubMed ID: 16039613
[TBL] [Abstract][Full Text] [Related]
8. Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1.
Kazemi-Esfarjani P; Benzer S
Hum Mol Genet; 2002 Oct; 11(21):2657-72. PubMed ID: 12354791
[TBL] [Abstract][Full Text] [Related]
9. Hosting neurotoxicity in polyglutamine disease.
Liu N; Bonini NM
Cell; 2006 Dec; 127(7):1299-300. PubMed ID: 17190592
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases.
Qi ML; Tagawa K; Enokido Y; Yoshimura N; Wada Y; Watase K; Ishiura S; Kanazawa I; Botas J; Saitoe M; Wanker EE; Okazawa H
Nat Cell Biol; 2007 Apr; 9(4):402-14. PubMed ID: 17384639
[TBL] [Abstract][Full Text] [Related]
11. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila.
Kretzschmar D; Tschäpe J; Bettencourt Da Cruz A; Asan E; Poeck B; Strauss R; Pflugfelder GO
Glia; 2005 Jan; 49(1):59-72. PubMed ID: 15390099
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
Stenoien DL; Mielke M; Mancini MA
Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases.
Ghosh S; Feany MB
Hum Mol Genet; 2004 Sep; 13(18):2011-8. PubMed ID: 15254017
[TBL] [Abstract][Full Text] [Related]
14. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation.
Fayazi Z; Ghosh S; Marion S; Bao X; Shero M; Kazemi-Esfarjani P
Neurobiol Dis; 2006 Nov; 24(2):226-44. PubMed ID: 16934481
[TBL] [Abstract][Full Text] [Related]
15. Bax-like protein Drob-1 protects neurons from expanded polyglutamine-induced toxicity in Drosophila.
Senoo-Matsuda N; Igaki T; Miura M
EMBO J; 2005 Jul; 24(14):2700-13. PubMed ID: 16001086
[TBL] [Abstract][Full Text] [Related]
16. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases.
Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M
Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Drosophila myeloid leukemia factor.
Martin-Lannerée S; Lasbleiz C; Sanial M; Fouix S; Besse F; Tricoire H; Plessis A
Genes Cells; 2006 Dec; 11(12):1317-35. PubMed ID: 17121541
[TBL] [Abstract][Full Text] [Related]
18. Polyglutamine diseases: a transcription disorder?
Okazawa H
Cell Mol Life Sci; 2003 Jul; 60(7):1427-39. PubMed ID: 12943229
[TBL] [Abstract][Full Text] [Related]
19. Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
Fornai F; Soldani P; Lazzeri G; di Poggio AB; Biagioni F; Fulceri F; Batini S; Ruggieri S; Paparelli A
Brain Res Bull; 2005 Apr; 65(4):275-90. PubMed ID: 15811592
[TBL] [Abstract][Full Text] [Related]
20. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
